Key Features and Values
- Same sample type can be used across all assays to simplify inclusion into routine serology work-up
- Ready to use reagents reduces hands-on time for assay preparation
- Long shelf life cost-effective solution by reducing wastage due to expired kits
- Suitable for inclusion on automated plate systems simplifies scale-up of test volume
- Supported by a complete panel of assays for supporting treatment monitoring of several forms of cancer
Total PSA ELISA is used for the quantitative determination of total Prostate Specific Antigen (t-PSA) in human serum or plasma samples. The determination of total PSA levels is used to help estimate the risk of prostate carcinoma in men in conjunction with digital rectal examination (DRE) or to help monitor the effectiveness of prostate carcinoma treatment in patients.
1. Fritsche HA und RJ. Babalan Clin Chem (1993) Vol 39: 1529-1529 Analytical performance goals for measuring prostate-specific antigen
2. Milford Ward A. et al., Ann Clin Biochem (2001), Vol 38: 633-651 Prostate specific antigen: biology, biochemistry and available commercial assays.
3. Price C. P. et al., Ann Clin Biochem (2001), Vol 38: 188-216 Pre-and post-analytical factors that may influence use of serum prostrate specific antigen and its isoforms in a screening programme for prostate cancer.
4. Lange P et al., J Urol (1989) Vol 141:873. The value of serum prostate-specific antigen determinations before and after radical prostatectomy.
5. Akdas et al. British J Uro (1997) Vol 79: 920-923. The role of free prostate specific antigen in the diagnosis of prostate cancer.